GW&K Investment Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-291,821
Closed -$19.3M 235
2016
Q3
$19.3M Buy
291,821
+34,957
+14% +$2.39M 0.36% 124
2016
Q2
$18.6M Sell
256,864
-63,025
-20% -$4.33M 0.38% 111
2016
Q1
$20.7M Buy
319,889
+24,217
+8% +$1.61M 0.46% 97
2015
Q4
$21.2M Buy
295,672
+1,867
+0.6% +$138K 0.5% 89
2015
Q3
$22.6M Buy
293,805
+22,178
+8% +$1.79M 0.54% 79
2015
Q2
$20.1M Buy
271,627
+5,531
+2% +$398K 0.46% 92
2015
Q1
$19.3M Buy
266,096
+36,445
+16% +$2.53M 0.44% 91
2014
Q4
$15.2M Buy
229,651
+45,166
+24% +$2.76M 0.36% 103
2014
Q3
$10.1M Sell
184,485
-15,932
-8% -$904K 0.27% 121
2014
Q2
$11.7M Buy
200,417
+6,671
+3% +$393K 0.3% 114
2014
Q1
$12M Buy
193,746
+104,696
+118% +$6.09M 0.32% 113
2013
Q4
$4.75M Buy
89,050
+11,264
+14% +$605K 0.13% 148
2013
Q3
$3.9M Buy
77,786
+2,956
+4% +$144K 0.12% 146
2013
Q2
$3.43M Buy
+74,830
New +$3.35M 0.13% 147

Other funds holding MD

GW&K Investment Management's MD Position: Q4 2016 in Review

GW&K Investment Management sold out of Pediatrix Medical (MD) in Q4 2016, closing a stake of 291,821 shares — an estimated $19.3M sold.

GW&K Investment Management first reported a position in MD in Q2 2013 and held it in 14 quarters. The position peaked at $22.6M in Q3 2015. 383 funds tracked by Wall St. Rank hold MD as of Q4 2016.

  • GW&K Investment Management reported no remaining Pediatrix Medical position as of Q4 2016 after selling out during the quarter.
  • GW&K Investment Management sold 291,821 Pediatrix Medical shares in Q4 2016, an estimated $19.3M.
  • GW&K Investment Management first reported a position in Pediatrix Medical in Q2 2013 and held it in 14 quarters.
  • GW&K Investment Management's Pediatrix Medical position peaked at $22.6M in Q3 2015.
  • 383 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2016.

Based on GW&K Investment Management's 13F filing for Q4 2016, filed 17 Jan 2017.